Commodity | Reporter | Partner | Trade flow | Indicator | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
3002. Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc | Ireland | USA | Exports | Value (US$) | 4,873,782,197.00 | 573,961,681.00 | 610,908,393.65 | 936,947,273.10 | 2,529,575,372.36 | 4,003,567,649.26 | 7,168,933,853.76 | 13,042,902,506.59 | 17,704,136,427.91 | 19,191,769,326.96 | 22,215,144,886.06 | 20,238,047,145.70 |
Value Growth, YoY (%) | 104.99 | -88.22 | 6.43 | 53.36 | 169.98 | 58.27 | 79.06 | 81.93 | 35.73 | 8.40 | 15.75 | -8.89 |
The value of exports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" from Ireland to USA totalled $ 20 billion in 2022. Sales of commodity group 3002 from Ireland to USA declined by 8.89% compared to 2021.exports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" decreased by $ 1.97 billion (exports of commodity group 3002 from Ireland to USA were equal to $22 billion in 2021)
Exports of "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" from Ireland to USA accounted for 30% of the total merchandise exports in 2022 (total sales of goods from Ireland to USA were equal to $ 66 billion in 2022). The share of commodity group 3002 in overall exports from Ireland to USA went down by 5.32 p.p. compared to 2021 (it was 35% in 2021 and cumulative exports from Ireland to USA were equal to $ 62 billion).
Exports of commodity group 3002 accounted for 79% of total sales of commodity group "" from Ireland to USA in 2022 (cumulative exports of commodity group from Ireland to USA were equal to $25 billion in 2022). The share of exports of commodity group 3002 in sales of commodity group from Ireland to USA went up by 3.04 p.p. compared to 2021 (it was 76% in 2021, and exports of commodity group from Ireland to USA were $29 billion).
The share of USA in total exports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" from Ireland was 41 percent (20 billion USD) in 2022 of 48 billion USD - the value of overall merchandise exports of commodity group 3002 from Ireland in 2022. The share of USA in exports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" from Ireland decreased by -9.06 p.p. in value terms compared to 2021 (it was 50 percent in 2021, and overall exports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" from Ireland amounted to 43 billion USD).